Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Never Ending Struggle Against Development of Drug Resistance.
Daskapan A, Stienstra Y, Akkerman OW, de Lange WC, Kosterink JG, van der Werf TS, Alffenaar JW. Daskapan A, et al. Clin Infect Dis. 2015 Jul 1;61(1):137-8. doi: 10.1093/cid/civ238. Epub 2015 Mar 25. Clin Infect Dis. 2015. PMID: 25810289 No abstract available.
Raltegravir and rifampicin in patients with HIV and tuberculosis.
Klis S, Daskapan A, Akkerman OW, Alffenaar JW, Stienstra Y. Klis S, et al. Among authors: daskapan a. Lancet Infect Dis. 2014 Nov;14(11):1046-1047. doi: 10.1016/S1473-3099(14)70977-6. Epub 2014 Oct 19. Lancet Infect Dis. 2014. PMID: 25444405 No abstract available.
Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting.
Van't Boveneind-Vrubleuskaya N, Daskapan A, Kosterink JG, van der Werf TS, van den Hof S, Alffenaar JC. Van't Boveneind-Vrubleuskaya N, et al. Among authors: daskapan a. PLoS One. 2016 Nov 10;11(11):e0166030. doi: 10.1371/journal.pone.0166030. eCollection 2016. PLoS One. 2016. PMID: 27832142 Free PMC article.
Risk factors contributing to a low darunavir plasma concentration.
Daskapan A, Stienstra Y, Kosterink JGW, Bierman WFW, van der Werf TS, Touw DJ, Alffenaar JC. Daskapan A, et al. Br J Clin Pharmacol. 2018 Mar;84(3):456-461. doi: 10.1111/bcp.13464. Epub 2017 Dec 7. Br J Clin Pharmacol. 2018. PMID: 29077230 Free PMC article.
A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs.
Daskapan A, Idrus LR, Postma MJ, Wilffert B, Kosterink JGW, Stienstra Y, Touw DJ, Andersen AB, Bekker A, Denti P, Hemanth Kumar AK, Jeremiah K, Kwara A, McIlleron H, Meintjes G, van Oosterhout JJ, Ramachandran G, Rockwood N, Wilkinson RJ, van der Werf TS, Alffenaar JC. Daskapan A, et al. Clin Pharmacokinet. 2019 Jun;58(6):747-766. doi: 10.1007/s40262-018-0716-8. Clin Pharmacokinet. 2019. PMID: 30406475 Free PMC article.
Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data.
Daskapan A, Tran QTD, Cattaneo D, Gervasoni C, Resnati C, Stienstra Y, Bierman WFW, Kosterink JGW, van der Werf TS, Proost JH, Alffenaar JC, Touw DJ. Daskapan A, et al. Ther Drug Monit. 2019 Feb;41(1):59-65. doi: 10.1097/FTD.0000000000000576. Ther Drug Monit. 2019. PMID: 30489547 Free PMC article.
18 results